Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 USD | +0.95% | -7.02% | -2.75% |
Business Summary
Number of employees: 72
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products
100.0
%
| 15 | 100.0 % | 9 | 100.0 % | -39.16% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 15 | 100.0 % | 9 | 100.0 % | -39.16% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 17/18/17 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 14/22/14 |
Chief Operating Officer | - | 01/10/01 | |
Gary S. Hogge
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/18/01 |
Ioana C. Hone
IRC | Investor Relations Contact | - | - |
George Samuel
LAW | General Counsel | 43 | 01/21/01 |
Derek Kelaita
PRN | Corporate Officer/Principal | - | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 01/09/01 |
Brian Culley
CEO | Chief Executive Officer | 53 | 17/18/17 |
Director/Board Member | 66 | 11/14/11 | |
Don Bailey
BRD | Director/Board Member | 78 | 01/20/01 |
Angus Russell
BRD | Director/Board Member | 68 | 09/14/09 |
Michael Mulroy
CHM | Chairman | 58 | 04/14/04 |
Director/Board Member | 67 | 04/21/04 | |
Dipti Amin
BRD | Director/Board Member | 60 | 20/21/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 188,798,145 | 187,985,347 ( 99.57 %) | 0 | 99.57 % |
Company contact information
Lineage Cell Therapeutics, Inc.
2173 Salk Avenue Suite 200
92008-7354, Carlsbad
+442 287 8990
http://www.lineagecell.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.75% | 200M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- LCTX Stock
- Company Lineage Cell Therapeutics, Inc.